Figure 5.Assessment of publication bias for progression-free survival. (A) Patients with liver metastases. (B) Patients without liver metastases.
Figure 5 — Impact of liver metastases status on survival outcomes of first-line immunotherapy in extensive stage small cell lung cancer: a systematic review and meta-analysis | Aging
